Citadel Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Sell
3,000
-1,600
-35% -$230K ﹤0.01% 9880
2025
Q4
$656K Sell
4,600
-2,000
-30% -$268K ﹤0.01% 8355
2025
Q3
$792K Buy
+6,600
New +$836K ﹤0.01% 8050
2025
Q2
Sell
-1,600
Closed -$222K 13667
2025
Q1
$222K Sell
1,600
-2,000
-56% -$310K ﹤0.01% 10248
2024
Q4
$559K Buy
3,600
+2,800
+350% +$474K ﹤0.01% 8311
2024
Q3
$146K Sell
800
-3,800
-83% -$563K ﹤0.01% 10600
2024
Q2
$546K Buy
4,600
+1,600
+53% +$168K ﹤0.01% 7872
2024
Q1
$322K Buy
3,000
+300
+11% +$29.8K ﹤0.01% 9297
2023
Q4
$269K Buy
2,700
+2,100
+350% +$205K ﹤0.01% 9369
2023
Q3
$71.4K Sell
600
-5,100
-89% -$761K ﹤0.01% 11307
2023
Q2
$1.02M Buy
5,700
+2,200
+63% +$404K ﹤0.01% 6424
2023
Q1
$577K Sell
3,500
-4,400
-56% -$757K ﹤0.01% 8025
2022
Q4
$1.24M Buy
7,900
+2,800
+55% +$426K ﹤0.01% 6391
2022
Q3
$768K Buy
+5,100
New +$849K ﹤0.01% 7564
2022
Q2
Sell
-3,600
Closed -$802K 13411
2022
Q1
$802K Sell
3,600
-11,000
-75% -$2.46M ﹤0.01% 8220
2021
Q4
$3.46M Sell
14,600
-6,200
-30% -$1.45M ﹤0.01% 5054
2021
Q3
$4.85M Buy
20,800
+15,800
+316% +$3.31M ﹤0.01% 4357
2021
Q2
$1.03M Sell
5,000
-6,800
-58% -$1.4M ﹤0.01% 8298
2021
Q1
$2.42M Buy
+11,800
New +$2.49M ﹤0.01% 5954

Other funds holding ICUI

Citadel Advisors's ICUI Position: Q1 2026 in Review

Citadel Advisors increased its ICU Medical (ICUI) stake by 58% in Q1 2026, buying an estimated $17.6M and bringing the position to 333,336 shares worth $43.1M. The position accounts for 0.01% of the portfolio, ranked #1509.

Citadel Advisors first reported a position in ICUI in Q2 2013 and has held it in 45 quarters since. The position peaked at $119M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Citadel Advisors held 333,336 shares of ICU Medical worth $43.1M as of Q1 2026.
  • Citadel Advisors bought 122,437 ICU Medical shares in Q1 2026, an estimated $17.6M.
  • ICU Medical made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1509 holding.
  • Citadel Advisors first reported a position in ICU Medical in Q2 2013 and has held it in 45 quarters since.
  • Citadel Advisors's ICU Medical position peaked at $119M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.